Humidified high-flow nasal oxygen
DeviceHumidified high-flow oxygen delivered via the Optiflow device
NCT Number: NCT05839665
The goal of this randomised cross-over study is to compare pre-oxygenation using a standard nasal cannula to pre-oxygenation using humidified high-flow nasal oxygen and a tight-fitting facemask in adult volunteers with a BMI below 30 not suffering from pulmonary or cardiac comorbidity.
The main question it aims to answer is:
- Are there any differences in the effectiveness of pre-oxygenation using a standard nasal cannula compared to using a traditional facemask and pre-oxygenation using humidified high-flow nasal oxygen?
Participants will be pre-oxygenated with 100% oxygen during four minutes intervals. All participants will be pre-oxygenated with various flow rates using a standard nasal cannula, a facemask and humidified high-flow nasal oxygen. End-tidal oxygen concentrations will be measured continuously in order to evaluate the effectiveness of pre-oxygenation.
Each volunteer will be pre-oxygenated repeatedly, with different flow rates, with all three methods of pre-oxygenation and act as its own control.
During facemask pre-oxygenation volunteers will be pre-oxygenated using both tidal volume breathing for four minutes and with eight vital capacity breaths. During pre-oxygenation using the standard nasal cannula flow rates will vary between 15 and 50 l/min. Pre-oxygenation using humidified high-flow nasal oxygen will be performed with flow rates varying between 30 and 50 l/min. Series will be conducted with volunteers breathing with both opened and closed mouth as well as with four minutes of tidal volume breathing and eight vital capacity breaths.
All volunteers will start with facemask pre-oxygenation. They will thereafter be randomised to pre-oxygenation with either a standard nasal cannula or humidified high-flow nasal oxygen. Lastly, they will be pre-oxygenated with the remaining method according to the randomisation.
Looking for future studies?
Notify Me25 year–65 year
All sexes
Interventional
Not applicable
Karolinska University Hospital, Solna, Stockholm, Sweden
Pre-oxygenation before anaesthesia induction is mostly performed using a tight-fitting facemask. Recently, studies have shown that pre-oxygenation using humidified high-flow nasal oxygen is equally effective as pre-oxygenation using a standard tight-fitting facemask. Pre-oxygenation using humidified high-flow nasal oxygen has several potential advantages including improved patient comfort and the possibility of a seamless transition from pre-oxygenation to apnoeic oxygenation. Unfortunately, this technique requires an additional machine which can be expensive and also difficult to use in settings outside a hospital.
In this study, pre-oxygenation using a standard nasal cannula delivering a high flow of oxygen will be compared with standard facemask pre-oxygenation and pre-oxygenation using humidified high-flow nasal oxygen in adult volunteers with a BMI below 30 not suffering from pulmonary or cardiac comorbidity.
The main question it aims to answer is:
Participants will be pre-oxygenated with 100% oxygen during four minutes intervals. All participants will be pre-oxygenated with various flow rates using a standard nasal cannula, a facemask and humidified high-flow nasal oxygen. End-tidal oxygen concentrations will be measured continuously in order to evaluate the effectiveness of pre-oxygenation.
Each volunteer will be pre-oxygenated repeatedly, with different flow rates, with all three methods of pre-oxygenation and act as its own control.
During facemask pre-oxygenation volunteers will be pre-oxygenated using both tidal volume breathing for four minutes and with eight vital capacity breaths. During pre-oxygenation using the standard nasal cannula flow rates will vary between 15 and 50 l/min. Pre-oxygenation using humidified high-flow nasal oxygen will be performed with flow rates varying between 30 and 50 l/min. Series will be conducted with volunteers breathing with both opened and closed mouth as well as with four minutes of tidal volume breathing and eight vital capacity breaths.
All volunteers will start with facemask pre-oxygenation. They will thereafter be randomised to pre-oxygenation with either a standard nasal cannula or humidified high-flow nasal oxygen. Lastly, they will be pre-oxygenated with the remaining method according to the randomisation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Humidified high-flow oxygen delivered via the Optiflow device
Oxygen delivered with high flows via a standard nasal cannula
Oxygen delivered with facemask
Time frame: After 3 minutes of preoxygenation
Compare end-tidal oxygen levels after three minutes of pre-oxygenation using a standard facemask, high-flow nasal oxygen and a standard nasal cannula.
Time frame: After 3 minutes of preoxygenation
Evaluation of end-tidal oxygen levels will be done each minute during all series of pre-oxygenation in order to investigate the time taken until reaching end-tidal levels above 80%. A comparison between the time taken to achieve end-tidal levels above 80% will be done between the different methods of pre-oxygenation as well as the different flow rates.
Time frame: After 3 minutes of preoxygenation
Evaluation of end-tidal oxygen levels will be done each minute during all series of pre-oxygenation in order to investigate the time taken until reaching end-tidal levels above 85%. A comparison between the time taken to achieve end-tidal levels above 80% will be done between the different methods of pre-oxygenation as well as the different flow rates.
Time frame: After 3 minutes of preoxygenation
Evaluation of end-tidal oxygen levels will be done after one, two, three and four minutes of pre-oxygenation. Comparison between the different methods and flow rates of pre-oxygenation will be done in order to evaluate which method and flow rate generates adequate end-tidal oxygen levels most quickly.
Time frame: After 3 minutes of preoxygenation
All volunteers will be pre-oxygenated with both open and closed mouths in order to evaluate if there are any differences in end-tidal oxygen levels when breathing with open or closed mouth.
Time frame: After 3 minutes of preoxygenation
End-tidal oxygen levels during pre-oxygenation will be evaluated and compared between tidal volume breathing for three minutes and eight vital capacity breaths.
Time frame: After 3 minutes of preoxygenation
Subgroup analysis will be performed in order to investigate any differences in the effect of pre-oxygenation depending on volunteer age, body mass index or sex.
Time frame: After 3 minutes of preoxygenation
Level of discomfort, on a scale between one and ten, where ten is the worst discomfort and 0 is the best comfort) will be compared between the three different methods of pre-oxygenation and the different flow rates.
Time frame: After 3 minutes of preoxygenation
Do more volunteers report problem with headache or nosebleed during pre-oxygenation with the standard nasal cannula compared to pre-oxygenation with facemask or humidified high-flow nasal oxygen?
Malin Jonsson Fagerlund
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06993740
Anesthesia, Cardiovascular Diseases
Jakarta, DKI Jakarta, Indonesia
View Trial DetailsNCT07259629
Anesthesia, Glucose Metabolism Disorders
Exeter, Devon, United Kingdom
View Trial DetailsNCT03972423
Anesthesia, Anesthesia Complication
Versailles, IDF, France
View Trial DetailsNCT05111340
Aberrant Motor Behavior in Dementia, Anesthesia
Arras, France
View Trial Details